We are live on ! Find out more
SGYP

Synergy Pharmaceuticals, Inc Common Stock
SGYP

Delisted

SGYP was delisted on the 7th of March, 2019.

Back to rankings

12 hedge funds and large institutions have $1K invested in Synergy Pharmaceuticals, Inc Common Stock in 2019 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 79 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

87% less funds holding

Funds holding: 89 → 12 (-77)

97% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 79

100% less capital invested

Capital invested by funds: $4.12M → $1K (-$4.12M)

Holders
12
Holders Change
-77
Holders Change %
-86.52%
% of All Funds
0.26%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
3
Closed
79
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
TRCT
Tower Research Capital (TRC)
New York
+$23.7K
2
WS
Wedbush Securities
California
+$8.3K
3
BWA
BDO Wealth Advisors
Florida
+$1.02K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$1.38M
2
State Street
State Street
Massachusetts
-$495K
3
Vanguard Group
Vanguard Group
Pennsylvania
-$361K
4
Northern Trust
Northern Trust
Illinois
-$281K
5
JG
Jefferies Group
New York
-$195K
Name Holding Trade Value Shares
Change 		Change in
Stake
Brown Advisory
26
Brown Advisory
Maryland
– -$24K -212,947 Closed
Manulife (Manufacturers Life Insurance)
27
Manulife (Manufacturers Life Insurance)
Ontario, Canada
– -$21K -185,473 Closed
AIG
28
American International Group
New York
– -$19K -163,644 Closed
Bank of Montreal
29
Bank of Montreal
Ontario, Canada
– -$14K -130,224 Closed
AAM
30
Azzad Asset Management
Virginia
– -$13.6K -119,157 Closed
VOYA Investment Management
31
VOYA Investment Management
Georgia
– -$12K -104,372 Closed
HCM
32
Highbridge Capital Management
New York
– -$12K -100,000 Closed
CHP
33
Cable Hill Partners
Oregon
– -$11K -93,000 Closed
Group One Trading
34
Group One Trading
Illinois
– -$10K -90,658 Closed
BRWM
35
B. Riley Wealth Management
Tennessee
– -$10K -85,300 Closed
DekaBank Deutsche Girozentrale
36
DekaBank Deutsche Girozentrale
Germany
– -$7K -80,500 Closed
State Board of Administration of Florida Retirement System
37
State Board of Administration of Florida Retirement System
Florida
– -$9K -80,256 Closed
Principal Financial Group
38
Principal Financial Group
Iowa
– -$9K -78,824 Closed
JP Morgan Chase
39
JP Morgan Chase
New York
– -$7K -63,491 Closed
SG Americas Securities
40
SG Americas Securities
New York
– -$7K -60,995 Closed
KBC Group
41
KBC Group
Belgium
– -$6K -56,500 Closed
HSA
42
HBK Sorce Advisory
Pennsylvania
– -$6K -52,135 Closed
HighTower Advisors
43
HighTower Advisors
Illinois
– -$5K -49,831 Closed
CS
44
Credit Suisse
Switzerland
– -$6K -48,981 Closed
RJA
45
Raymond James & Associates
Florida
– -$5K -43,718 Closed
Invesco
46
Invesco
Georgia
– -$5K -42,461 Closed
TCM
47
Traynor Capital Management
Pennsylvania
– -$9K -40,500 Closed
Legal & General Group
48
Legal & General Group
United Kingdom
– -$4K -38,418 Closed
AB
49
Amalgamated Bank
New York
– -$4K -37,420 Closed
AG
50
Advisor Group
Arizona
– -$4K -34,514 Closed
1
2
3 4

SGYP Hedge Fund Activity: Q1 2019 in Review

12 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Synergy Pharmaceuticals, Inc Common Stock (SGYP) for Q1 2019, worth a combined $1K — down 100% from $4.12M a quarter earlier.

Sellers outnumbered buyers: 79 funds closed out of SGYP and 2 opened new positions — a net loss of 77 holders — while 3 trimmed existing stakes and 2 added.

The largest buyer was Tower Research Capital (TRC), adding an estimated $23.7K. The largest seller was BlackRock, exiting entirely with an estimated $1.38M sold.

  • 12 institutional investors held Synergy Pharmaceuticals, Inc Common Stock (SGYP) as of Q1 2019, down from 89 in Q4 2018.
  • Funds reported $1K of Synergy Pharmaceuticals, Inc Common Stock stock for Q1 2019, down 100% quarter-over-quarter.
  • 2 funds opened new Synergy Pharmaceuticals, Inc Common Stock positions in Q1 2019 and 79 closed out, a net change of -77 holders.
  • The largest Synergy Pharmaceuticals, Inc Common Stock buyer in Q1 2019 was Tower Research Capital (TRC), an estimated $23.7K added.
  • The largest Synergy Pharmaceuticals, Inc Common Stock seller in Q1 2019 was BlackRock, an estimated $1.38M sold.

Based on aggregated 13F filings for Q1 2019.